Inmune Bio (INMB) Return on Sales [ROS] (2021 - 2025)
Inmune Bio (INMB) posted Return on Sales [ROS] of -94766.00% for Q4 2025, up 209769.71 percentage points from -304535.71% a year earlier and up 7986.00 percentage points from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Return on Sales [ROS] (2021 - 2025) Analysis & Trends
Since Q1 2021, Inmune Bio has reported Return on Sales [ROS] for 20 quarters.
- Annual Return on Sales [ROS] shows a five-year change of +16397.64 percentage points (FY2020 to FY2025).
- In prior years, Inmune Bio's Return on Sales [ROS] was -304535.71% in FY2024 (-285347.97 pp), -19187.74% in FY2023 (-12248.97 pp), -6938.77% in FY2022 (+9167.86 pp) and -16106.63% in FY2021 (+95057.01 pp).
- Quarterly Return on Sales [ROS] has run from a low of -478275.00% in Q2 2021 to a high of -3974.23% in Q1 2022 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in two of the last eight quarters, with an average year-over-year change of -31148.61 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2022, with a gain of 438350.00 percentage points; the weakest was Q4 2024, with a drop of 274610.71 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -102752.00% (Q3 2025), -112458.00% (Q2 2025) and -19810.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Inmune Bio | 53.37 Mn | -38.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -94,766.00% |
| Sep 30, 2025 | -102,752.00% |
| Jun 30, 2025 | -112,458.00% |
| Mar 31, 2025 | -19,810.00% |
| Dec 31, 2024 | -304,535.71% |
| Sep 30, 2024 | -98,921.43% |
| Jun 30, 2024 | -44,457.65% |
| Mar 31, 2024 | -78,692.86% |
| Dec 31, 2023 | -29,925.00% |
| Sep 30, 2023 | -19,832.56% |
| Jun 30, 2023 | -13,936.96% |
| Mar 31, 2023 | -16,902.63% |
| Dec 31, 2022 | -5,816.49% |
| Sep 30, 2022 | -7,594.90% |
| Jun 30, 2022 | -39,925.00% |
| Mar 31, 2022 | -3,974.23% |
| Dec 31, 2021 | -5,539.88% |
| Sep 30, 2021 | -64,435.71% |
| Jun 30, 2021 | -478,275.00% |
| Mar 31, 2021 | -113,700.00% |
API Access
Inmune Bio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();